3 active not recruiting, 3 completed, 2 recruiting, 2 unknown. 11 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 11 | Active not recruiting 3, Completed 3, Recruiting 2, Unknown 2, Not yet recruiting 1 |
| Phase 3 | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow Colorectal Adenoma: new trials by email Literature Review of Colorectal Adenoma trials Research Report on Colorectal Adenoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II Clinical Study of AC591 in Preventing Oxaliplatin-Induced Peripheral Neuropathy CAPEOX, Placebo, AC591 - Colorectal Adenoma | Phase 2 | Not yet recruiting | Shandong New Time Pharmaceutical Co., LTD | 120 | 2024-12-01 | 2024-12-09 |
| Evaluation of Gixam's Performance in a FIT Negative Population colorectal cancer (CRC) screening, colorectal cancer screening, Colonoscopy after bowel cleansing - Colorectal Adenoma, Colorectal Cancer (CRC) | Phase 2 | Recruiting | Jubaan Ltd. | 400 | 2024-11-01 | 2024-11-14 |
| Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Reducing Recurrence of Colorectal Adenoma (CRA) fecal microbiota transplantation - Fecal Microbiota Transplantation, Colorectal Adenoma | Phase 2 | Recruiting | Shenzhen Hospital of Southern Medical University | 466 | 2024-04-09 | 2024-07-15 |
| The Colorectal Cancer Chemoprevention Acceleration and Improvement Platform (CRC-CHAMP) Study acetylsalicylic acid delayed release tablets, 81mg - Colorectal Cancer, Colorectal Adenoma | Phase 2 | Unknown | University of Calgary | 100 | 2022-07-01 | 2022-06-02 |
| PRevention Using EPA Against coloREctal Cancer AMR101 - Colorectal Adenoma, Colorectal Cancer | Phase 1 / Phase 2 | Completed | Massachusetts General Hospital | 81 | 2020-12-09 | 2024-05-03 |
| Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer Linaclotide, Placebo - Colorectal Adenoma, Stage 0 Colorectal Cancer AJCC v8 | Phase 2 | Active not recruiting | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 150 | 2019-10-30 | 2026-10-08 |
| Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma Aspirin, Biospecimen Collection, Placebo Administration - Colorectal Adenoma, Colorectal Carcinoma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 81 | 2018-01-16 | 2026-08-06 |
| Study of Berberine Hydrochloride in Prevention of Colorectal Adenomas Recurrence Berberine hydrochloride, placebo - Colorectal Adenoma | Phase 2 / Phase 3 | Completed | Shanghai Jiao Tong University School of Medicine | 1108 | 2014-11-01 | 2019-03-26 |
| Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps Laboratory Biomarker Analysis, MUC1 Peptide-Poly-ICLC Vaccine, Quality-of-Life Assessment - Colorectal Adenoma, Colorectal Carcinoma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 110 | 2014-06-23 | 2026-09-11 |
| Study of Calcium Plus Vitamin D Supplementation in Prevention of Colorectal Adenomas Recurrence Ca plus vit D - Colorectal Adenoma | Phase 2 / Phase 3 | Unknown | Shanghai Jiao Tong University School of Medicine | 900 | 2014-03-01 | 2014-05-21 |
| Evaluation of Surgically Resected Colorectal Adenomas and Carcinomas After 7 Days Pretreatment With Celecoxib Celecoxib, Placebo - Colorectal Adenoma, Colorectal Carcinoma | Phase 2 | Completed | University of Alabama at Birmingham | 40 | 2001-12-01 | 2017-06-15 |
Colonic Diseases (7) · Digestive System Diseases (7) · Digestive System Neoplasms (7) · Gastrointestinal Diseases (7) · Gastrointestinal Neoplasms (7) · Intestinal Diseases (7) · Intestinal Neoplasms (7) · Neoplasms (7) · Neoplasms by Site (7) · Rectal Diseases (7)
Aspirin (2) · Calcium Carbonate (1) · Celecoxib (1) · Drug Evaluation (1) · Fecal Microbiota Transplantation (1) · Mass Screening (1) · Saline Solution (1) · Sodium Chloride (1) · Specimen Handling (1) · Tyrosine (1) · eicosapentaenoic acid ethyl ester (1) · linaclotide (1)
National Cancer Institute (NCI) (2) · Shanghai Jiao Tong University School of Medicine (2) · Jubaan Ltd. (1) · Massachusetts General Hospital (1) · Shandong New Time Pharmaceutical Co., LTD (1) · Shenzhen Hospital of Southern Medical University (1) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1) · University of Alabama at Birmingham (1) · University of Calgary (1)
United States (6) · China (3) · Canada (1) · Puerto Rico (1)
Jing-Yuan Fang, M.D., Ph.D (2) · Martin J Heslin, M.D. (1) · Mingyang Song, MD (1) · Qi Dai (1) · Robert E Schoen (1) · Robert Hilsden (1) · Scott Waldman, MD (1) · Ye Chen, MD (1)
PMID 31926918, PMID 37553874, PMID 40034042, PMID 42045958, PMID 42349681
N01CN00035 (1), N01CN00042 (1), P30CA015083 (1), P30CA060553 (1)